FIGURE

Fig. 10

ID

ZDB-FIG-220818-13

Publication

Volpatti et al., 2022 - X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition

Other Figures

All Figure Page

Back to All Figure Page

Fig. 10

DNA methylation changes in XLMTM patients. a Principal component plot of 416 CpG sites identified as differentially methylated in XLMTM (data generated on Illumina EPIC array platform). n = 12 discovery samples were used to identify signature (plotted in red), with n = 21 discovery “control” males (dark blue). Test samples used to validate the differential methylation signature include n = 7 additional XLMTM cases (MTM1 test; orange), n = 4 additional controls (Control test; light blue) and n = 5 ACTA1 samples (green). Axes represent the first three principal components (PCs) and the total variability for which they account. b Heatmap and hierarchical clustering of the CpG sites and samples plotted in a. Each column represents a patient sample (coloured as in a) and each row represents a single CpG (both ordered by Euclidean clustering). Heatmap colors represent scaled and mean centered percent methylation

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Neuropathol.